Your browser doesn't support javascript.
loading
Antitumor activities of the targeted multi-tyrosine kinase inhibitor lenvatinib (E7080) against RET gene fusion-driven tumor models.
Okamoto, Kiyoshi; Kodama, Kotaro; Takase, Kazuma; Sugi, Naoko Hata; Yamamoto, Yuji; Iwata, Masao; Tsuruoka, Akihiko.
Affiliation
  • Okamoto K; Eisai Co., Ltd., Tokodai 5-1-3, Tsukuba, Ibaraki, 300-2635, Japan. Electronic address: k4-okamoto@hhc.eisai.co.jp.
Cancer Lett ; 340(1): 97-103, 2013 Oct 28.
Article in En | MEDLINE | ID: mdl-23856031
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quinolines / Oncogene Proteins, Fusion / Proto-Oncogene Proteins c-ret / Neoplasms / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Cancer Lett Year: 2013 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Quinolines / Oncogene Proteins, Fusion / Proto-Oncogene Proteins c-ret / Neoplasms / Antineoplastic Agents Limits: Animals / Female / Humans Language: En Journal: Cancer Lett Year: 2013 Document type: Article Country of publication: